Abstract:
Background Involving children and adolescents (youth) living with HIV (YLWH) in research is critical for developing
appropriate HIV care services and interventions. However, this vulnerable population may not adequately weigh risks
against benefits when participating in research, forming an ethical concern, yet little is known about how YLWH per-
ceive these risks and benefits. To inform research-related policies and procedures, we sought perspectives of Kenyan
YLWH, their caregivers and subject matter experts (SMEs) on risks and benefits of participation in research in a setting
with a high burden of youth HIV infection.
Methods We conducted a qualitative inquiry on identifying, enrolling, and protecting YLWH (age 10–24 years)
in research using semi-structured interviews with YLWH involved in research, their caregivers, YLWH with no prior
research experience, and other SMEs at the AMPATH care and research sites in western Kenya. Transcripts were the-
matically analyzed and emerging themes derived to characterize perspectives of each group on risks and benefits
of engaging YLWH in research.
Results Interviews were conducted with 40 YLWH (50% female; median age 17.5 years), 20 caregivers (70% female),
and 39 SMEs [healthcare providers (N = 10), community leaders (N = 10) community advisory board members (N = 4),
IRB experts (N = 5), clinical researchers (N = 6), social science researchers (N = 4) and laboratory experts (N = 1).] Par-
ticipants in all groups identified accidental disclosure of HIV status, stigma and discrimination, risks of blood draws,
mental health effects, and coercion due to study compensation as risks of research involvement. Benefits fell into 5
categories: clinical, informational, personal, future and community or household benefits. Benefits included access
to health care, learning about HIV, gaining hope and community, improving HIV care, and reducing stigma. All partici-
pant groups largely held similar views; however, caregivers were the only group to identify misuse of study compen-
sation as a risk, and YLWH less frequently cited clinical benefits.
Conclusion These findings suggest that participants commonly cite indirect risks and benefits of research partici-
pation, yet these are often excluded from institutional guidelines for consent documentation. Researchers should
consider including indirect risks and benefits, such as the risk of stigma or the benefit of gaining knowledge and com-
munity, to study documentation.